Skip to content Skip to footer
Subscribe Now
VIEWPOINTS

Breaking New Ground in Oncology: Leonard Mazur from Citius Pharmaceuticals in Conversation with PharmaShots 

Shots:   Citius Pharmaceuticals celebrates its first-ever FDA approval with Lymphir, a novel therapy for relapsed or refractory cutaneous T-cell lymphoma     In an exclusive conversation, Leonard Mazur, Co-Founder and CEO at Citius Pharmaceuticals, shares insights on Lymphir’s launch strategy and its potential impact on the oncology landscape    Leonard also highlights Mino-Lok, Citius’ innovative…
October 6, 2025

Read more

THOUGHTSPOT

The Rise of Industrial Metaverse: Smarter Pharma Starts at AUTOMA+ 2025 

Digital transformation of the pharmaceutical industry is moving beyond buzzwords to real-world impact. At the Pharmaceutical Automation & Digitalisation Congress AUTOMA+ 2025 (24-25 November, Vösendorf, Austria), pharma leaders, including ZETA GmbH, Takeda and Sapio Sciences, are going to showcase how cutting-edge technologies, from digital twins and predictive analytics to minimal code platforms and AI-driven process…
September 23, 2025

Read more

INSIGHTS+

Know Your Investor: Cormorant Asset Management (September’25 Edition) 

Shots:  Welcome to the September edition of Know Your Investor, featuring leading investors fuelling healthcare & life sciences  This edition spotlights Cormorant Asset Management, an investment firm focused on biotechnology and healthcare companies  In 2024, Cormorant completed 31 investments ~$3.88B, spanning PIPEs, private financings, IPO, and venture rounds. For the full report, contact us at…
September 4, 2025

Read more

INSIGHTS+

Know Your Investor: Venrock Healthcare Capital Partners (August’25 Edition)   

Shots:     Welcome to the August edition of Know Your Investor, featuring leading venture capital firms fuelling innovation in healthcare and life sciences  This edition spotlights Venrock Healthcare Capital Partners, a venture capital fund focused on investments in both publicly and privately held healthcare companies  In 2024, Venrock Healthcare Capital Partners invested approximately $4.56B across six…
August 7, 2025

Read more

Know Your Investor: Alexandria Venture (May’25 Edition)
INSIGHTS+

Know Your Investor: Alexandria Venture (May’25 Edition)

Shots:     Welcome to the 2025 edition of Know Your Investor, spotlighting leading venture capital firms driving innovation in healthcare.  This edition features Alexandria Venture Investments, a firm committed to supporting disruptive life science companies that aim to improve human health.  In 2024, the firm invested approximately $2.7B across six public and private funding rounds, adding…
May 15, 2025

Read more

Announcements

PharmaShots Announces Strategic Data Partnership with AlphaSense 

PharmaShots is pleased to announce a new strategic data partnership with AlphaSense, marking an important milestone in our mission to elevate the quality, accessibility, and impact of insights across the biopharma and healthcare ecosystem.  This collaboration strengthens our commitment to reimagining intelligence and delivering unmatched industry updates that empower researchers, students, analysts, and biopharma professionals worldwide. By…
April 13, 2025

Read more

Know Your Investor RA Capital Management (January’25 Edition)
INSIGHTS+

Know Your Investor: RA Capital Management (January’25 Edition)

Shots:    The January Edition features RA Capital Management, a global multi-stage investment firm dedicated to healthcare and life sciences  In 2024, RA Capital added 74 companies to its portfolio, investing approximately $8.5B across seven funding rounds, including private and common funding  Welcome to the 2025 series of Know Your Investor, a meticulously crafted report highlighting…
January 16, 2025

Read more

Know Your Investor (June Edition): Google Ventures
INSIGHTS+

Know Your Investor (June Edition): Google Ventures

Shots: Google Ventures is an investment arm of Alphabet Inc. That invests profusely in seed-stage companies ranging from software and internet to healthcare, life sciences, and artificial intelligence among others Ever since 2016, GV pivoted to focusing on established companies. The company manages assets worth $10B and 400 active portfolio companies spanning across North America…
June 13, 2024

Read more

Spotlight Interview_David Esposito
CXO TALKS

Spotlight Interview: David Esposito CEO at ONL Therapeutics in a Stimulating Conversation with PharmaShots

“Spotlight-Company of the Month” offers a unique platform for biopharma, life sciences, and healthcare companies, allowing them to connect with their target audiences and like-minded people.  This month at PharmaShots’ Spotlight, we had an opportunity to engage in conversation with David Esposito CEO at ONL Therapeutics.  David discusses the company's lead candidate ONL1204, which is…
February 19, 2024

Read more

Load more